BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1693 related articles for article (PubMed ID: 18167216)

  • 1. Lymph node metastases of adenocarcinoma of the esophagus and esophagogastric junction.
    Zhang X; Watson DI; Jamieson GG
    Chin Med J (Engl); 2007 Dec; 120(24):2268-70. PubMed ID: 18167216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of the depth of tumor invasion and lymph node metastasis in superficially invasive (T1) esophageal adenocarcinoma.
    Liu L; Hofstetter WL; Rashid A; Swisher SG; Correa AM; Ajani JA; Hamilton SR; Wu TT
    Am J Surg Pathol; 2005 Aug; 29(8):1079-85. PubMed ID: 16006804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathological features and prognostic factors of adenocarcinoma of the esophagogastric junction according to Siewert classification: experiences at a single institution in Japan.
    Hosokawa Y; Kinoshita T; Konishi M; Takahashi S; Gotohda N; Kato Y; Daiko H; Nishimura M; Katsumata K; Sugiyama Y; Kinoshita T
    Ann Surg Oncol; 2012 Feb; 19(2):677-83. PubMed ID: 21822549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The range of tumor extension should have precedence over the location of the deepest tumor center in determining the regional lymph node grouping for widely extending esophageal carcinomas.
    Ueda Y; Shiozaki A; Itoi H; Okamoto K; Fujiwara H; Ichikawa D; Kikuchi S; Fuji N; Itoh T; Ochiai T; Yamagishi H
    Jpn J Clin Oncol; 2006 Dec; 36(12):775-82. PubMed ID: 17043058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The number of lymph nodes with metastasis predicts survival in patients with esophageal or esophagogastric junction adenocarcinoma who receive preoperative chemoradiation.
    Gu Y; Swisher SG; Ajani JA; Correa AM; Hofstetter WL; Liao Z; Komaki RR; Rashid A; Hamilton SR; Wu TT
    Cancer; 2006 Mar; 106(5):1017-25. PubMed ID: 16456809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of number and site of lymph node invasion on survival of adenocarcinoma of esophagogastric junction.
    Ielpo B; Pernaute AS; Elia S; Buonomo OC; Valladares LD; Aguirre EP; Petrella G; Garcia AT
    Interact Cardiovasc Thorac Surg; 2010 May; 10(5):704-8. PubMed ID: 20154347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of old and new TNM systems for nodal staging in adenocarcinoma of the gastro-oesophageal junction.
    de Manzoni G; Pedrazzani C; Verlato G; Roviello F; Pasini F; Pugliese R; Cordiano C
    Br J Surg; 2004 Mar; 91(3):296-303. PubMed ID: 14991629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Analysis of the survival in patients after surgical resection of thoracic esophageal cancer].
    Zhang HL; Liu RL; Shi YT; Wang ZC; Wang BH; Li YJ; Zhou LY; Ping YM
    Zhonghua Zhong Liu Za Zhi; 2009 Jul; 31(7):541-5. PubMed ID: 19950705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymph node involvement in advanced gastroesophageal junction adenocarcinoma.
    Pedrazzani C; de Manzoni G; Marrelli D; Giacopuzzi S; Corso G; Minicozzi AM; Rampone B; Roviello F
    J Thorac Cardiovasc Surg; 2007 Aug; 134(2):378-85. PubMed ID: 17662776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome of oesophagectomy for adenocarcinoma of the oesophagus and oesophagogastric junction.
    Zhang X; Watson DI; Jamieson GG; Lally C; Bessell JR; Devitt PG
    ANZ J Surg; 2005 Jul; 75(7):513-9. PubMed ID: 15972033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Long-term survival after eso-gastrectomy for esophagogastric junction adenocarcinoma--prospective study].
    Bîrlă R; Iosif C; Mocanu A; Gîndea C; Hoară P; Panaitescu E; Constantinoiu S
    Chirurgia (Bucur); 2008; 103(6):635-42. PubMed ID: 19274907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic factors for the survival of patients with esophageal carcinoma in the U.S.: the importance of tumor length and lymph node status.
    Eloubeidi MA; Desmond R; Arguedas MR; Reed CE; Wilcox CM
    Cancer; 2002 Oct; 95(7):1434-43. PubMed ID: 12237911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenocarcinoma of the esophagogastric junction in Japan.
    Yamamoto M; Baba H; Egashira A; Oki E; Ikebe M; Kakeji Y; Maehara Y
    Hepatogastroenterology; 2008; 55(81):103-7. PubMed ID: 18507087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of epidermal growth factor receptor in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome.
    Wang KL; Wu TT; Choi IS; Wang H; Resetkova E; Correa AM; Hofstetter WL; Swisher SG; Ajani JA; Rashid A; Albarracin CT
    Cancer; 2007 Feb; 109(4):658-67. PubMed ID: 17211865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prevalence of lymph node metastases in patients with T1 esophageal adenocarcinoma a retrospective review of esophagectomy specimens.
    Leers JM; DeMeester SR; Oezcelik A; Klipfel N; Ayazi S; Abate E; Zehetner J; Lipham JC; Chan L; Hagen JA; DeMeester TR
    Ann Surg; 2011 Feb; 253(2):271-8. PubMed ID: 21119508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Influence of number of removed lymph nodes on the TNM staging and survival in advanced esophageal carcinoma].
    Chen LQ; Hu CY; Zhang HL; He M; Meng XL; Ping YM
    Zhonghua Zhong Liu Za Zhi; 2007 Aug; 29(8):604-8. PubMed ID: 18210881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphadenectomy for adenocarcinoma of the gastroesophageal junction (GEJ): impact of adequate staging on outcome.
    Barbour AP; Rizk NP; Gonen M; Tang L; Bains MS; Rusch VW; Coit DG; Brennan MF
    Ann Surg Oncol; 2007 Feb; 14(2):306-16. PubMed ID: 17091329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenocarcinoma of the esophagogastric junction: the pattern of metastatic lymph node dissemination as a rationale for elective lymphatic target volume definition.
    Meier I; Merkel S; Papadopoulos T; Sauer R; Hohenberger W; Brunner TB
    Int J Radiat Oncol Biol Phys; 2008 Apr; 70(5):1408-17. PubMed ID: 18374226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Surgical treatment of gasto-esophageal junction adenocarcinoma: long-term results of a single Italian centre].
    Pedrazzani C; Pasini F; Giacopuzzi S; Bernini M; Ruzzenente A; Festini M; Tomasi I; Cristadoro L; de Manzoni G
    G Chir; 2004 Oct; 25(10):325-33. PubMed ID: 15756954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relations of proliferative activities of gastric carcinoma cells to lymphatic involvement, venous invasion and prognosis.
    Wu YF; Xu HM; Chen JQ
    Chin Med J (Engl); 2004 Oct; 117(10):1530-5. PubMed ID: 15498378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 85.